
Hepatic injury and COVID-19: Pathogenic mechanisms or Epiphenomena?
Author(s) -
Javier A. Cienfuegos,
Víctor Valenti,
Fernando Rotellar
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.7851/2021
Subject(s) - medicine , covid-19 , epiphenomenon , coronavirus infections , betacoronavirus , virology , intensive care medicine , epistemology , outbreak , philosophy , disease , infectious disease (medical specialty)
Ampuero J et al. analyzed the relationship between liver injury and clinical progression of the disease in a meta-analysis of over 5,000 COVID-19 patients. The authors reported an association between increased aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin levels with mortality, admission to Intensive Care and the development of complications, respectively.